These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 32725890)

  • 1. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
    Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
    Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.
    Xu W; Huang C; Fei L; Li Q; Chen L
    Clin Interv Aging; 2021; 16():675-685. PubMed ID: 33911856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
    Wang Q; Zhao H; Liu LG; Wang YB; Zhang T; Li MH; Xu YL; Gao GJ; Xiong HF; Fan Y; Cao Y; Ding R; Wang JJ; Cheng C; Xie W
    Mil Med Res; 2020 Jun; 7(1):28. PubMed ID: 32507110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
    Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
    Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Abnormal liver function tests.
    Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
    J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study.
    Wang J; Zhu L; Xue L; Liu L; Yan X; Yan X; Huang S; Zhang B; Xu T; Li C; Ji F; Ming F; Zhao Y; Cheng J; Shao H; Chen K; Zhao XA; Sang D; Zhao H; Guan X; Chen X; Chen Y; Liu J; Huang R; Zhu C; Wu C
    J Med Virol; 2021 Jun; 93(6):3305-3311. PubMed ID: 33174624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
    Lv Y; Zhao X; Wang Y; Zhu J; Ma C; Feng X; Ma Y; Zheng Y; Yang L; Han G; Xie H
    Front Med (Lausanne); 2021; 8():639855. PubMed ID: 34179034
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.
    Lei F; Liu YM; Zhou F; Qin JJ; Zhang P; Zhu L; Zhang XJ; Cai J; Lin L; Ouyang S; Wang X; Yang C; Cheng X; Liu W; Li H; Xie J; Wu B; Luo H; Xiao F; Chen J; Tao L; Cheng G; She ZG; Zhou J; Wang H; Lin J; Luo P; Fu S; Zhou J; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu L; Chen G; Li H; Huang X; Zhang BH; Yuan Y
    Hepatology; 2020 Aug; 72(2):389-398. PubMed ID: 32359177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
    Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
    Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Biochemistries in Hospitalized Patients With COVID-19.
    Bloom PP; Meyerowitz EA; Reinus Z; Daidone M; Gustafson J; Kim AY; Schaefer E; Chung RT
    Hepatology; 2021 Mar; 73(3):890-900. PubMed ID: 32415860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
    Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of liver test abnormalities on the prognosis of COVID-19.
    Medetalibeyoglu A; Catma Y; Senkal N; Ormeci A; Cavus B; Kose M; Bayramlar OF; Yildiz G; Akyuz F; Kaymakoglu S; Tukek T
    Ann Hepatol; 2020; 19(6):614-621. PubMed ID: 32920162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
    Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
    Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hepatic enzymes activities in COVID-19 patients.
    Hwaiz R; Merza M; Hamad B; HamaSalih S; Mohammed M; Hama H
    Int Immunopharmacol; 2021 Aug; 97():107701. PubMed ID: 33930704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
    Li T; Deng C; Du Q; Yue R; Lu S; Chen H; Guo Y; Huang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):928-932. PubMed ID: 32912404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.